Yang Zhijun
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer (NCT03298074) | Yang Zhijun | 2017-10-01 |
Track Yang Zhijun automatically
Every clearance here is in the API, with alerts when new ones post.